The Personalized Medicines market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Personalized Medicines market research report recommends a business strategy for present market participants to strengthen their position in the market.
According to the report, the Personalized Medicines market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Personalized Medicines market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.
Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Personalized Medicines market along with their effects over the forecast period. Similarly, according to the region Personalized Medicines market research report includes the study of opportunities available in the market situation.
The Personalized Medicines market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
Global Personalized Medicines Market Segmentation by Regions:
In regional analysis, Personalized Medicines market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Personalized Medicines market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.
North America Region for Personalized Medicines Market: Value and Forecast
Europe Region for Personalized Medicines Market: Value and Forecast
Asia Pacific Region for Personalized Medicines Market: Value and Forecast
Latin America Region for Personalized Medicines Market: Value and Forecast
Middle East and Africa for Personalized Medicines Market: Value and Forecast
Global Personalized Medicines Market Segmentation by Type:
On the basis of product type, global Personalized Medicines market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness
Global Personalized Medicines Market Segmentation by Applications:
On the basis of the end users/applications, Personalized Medicines research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Hospitals Pharmacies, Retail Pharmacies, Dietary Care Centers, Others
Major Key Players for Global Personalized Medicines Market:
The Personalized Medicines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. 3G Biotech, Qiagen, Quest Diagnostics, Abbott, Agendia NV, Laboratory Corporation of America, CardioDx Inc., Asuragen Inc, Foundation Medicine, Becton Dickinson, Sanofi, Illumina, 23andMe, Siemens Healthcare, GE Healthcare, Bristol-Myers Squibb, Pfizer, Amgen
Important Points Covered by Report:
Global Personalized Medicines research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Personalized Medicines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Personalized Medicines market for numerous purposes such as:
1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.
2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Personalized Medicines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Personalized Medicines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.
3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Personalized Medicines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.
According to the report, the Personalized Medicines market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Personalized Medicines market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.
Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Personalized Medicines market along with their effects over the forecast period. Similarly, according to the region Personalized Medicines market research report includes the study of opportunities available in the market situation.
The Personalized Medicines market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
| Report Parameters | Details of Parameter |
| Market Size | xx Million |
| Based Year | 2019 |
| Forecast Period Covered | 2019 – 2028 |
| Units for value | Revenue in USD million and CAGR from 2020 to 2028 |
| Covered Segments | Component, Types, Applications, End-Users, and more. |
| Product Type | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
| Applications | Hospitals Pharmacies, Retail Pharmacies, Dietary Care Centers, Others |
| Region Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | 3G Biotech, Qiagen, Quest Diagnostics, Abbott, Agendia NV, Laboratory Corporation of America, CardioDx Inc., Asuragen Inc, Foundation Medicine, Becton Dickinson, Sanofi, Illumina, 23andMe, Siemens Healthcare, GE Healthcare, Bristol-Myers Squibb, Pfizer, Amgen |
Global Personalized Medicines Market Segmentation by Regions:
In regional analysis, Personalized Medicines market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Personalized Medicines market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.
North America Region for Personalized Medicines Market: Value and Forecast
- U.S.
- Canada
Europe Region for Personalized Medicines Market: Value and Forecast
- UK
- Germany
- France
- Rest of the Europe
Asia Pacific Region for Personalized Medicines Market: Value and Forecast
- China
- Japan
- India
- Rest of the Asia Pacific
Latin America Region for Personalized Medicines Market: Value and Forecast
- Mexico
- Brazil
- Rest of the Latin America
Middle East and Africa for Personalized Medicines Market: Value and Forecast
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Global Personalized Medicines Market Segmentation by Type:
On the basis of product type, global Personalized Medicines market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness
Global Personalized Medicines Market Segmentation by Applications:
On the basis of the end users/applications, Personalized Medicines research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Hospitals Pharmacies, Retail Pharmacies, Dietary Care Centers, Others
Major Key Players for Global Personalized Medicines Market:
The Personalized Medicines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. 3G Biotech, Qiagen, Quest Diagnostics, Abbott, Agendia NV, Laboratory Corporation of America, CardioDx Inc., Asuragen Inc, Foundation Medicine, Becton Dickinson, Sanofi, Illumina, 23andMe, Siemens Healthcare, GE Healthcare, Bristol-Myers Squibb, Pfizer, Amgen
Important Points Covered by Report:
- To analyze the value of the Personalized Medicines market, according to the key region.
- To study the Personalized Medicines market current trends, prospects and also their participation in the entire sector.
- Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
- Report provides the detailed information about drivers, restraints and future scope of Personalized Medicines market.
- Report covers the information about historic data analysis as well as forecast period analysis.
Global Personalized Medicines research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Personalized Medicines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Personalized Medicines market for numerous purposes such as:
1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.
2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Personalized Medicines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Personalized Medicines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.
3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Personalized Medicines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.
1 Personalized Medicines Market Overview
1.1 Product Overview and Scope of Personalized Medicines
1.2 Personalized Medicines Segment by Type
1.2.1 Global Personalized Medicines Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Personalized Medicines Segment by Application
1.3.1 Personalized Medicines Sales Comparison by Application: (2020-2026)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Global Personalized Medicines Market Size Estimates and Forecasts
1.4.1 Global Personalized Medicines Revenue 2015-2026
1.4.2 Global Personalized Medicines Sales 2015-2026
1.4.3 Personalized Medicines Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Personalized Medicines Industry Impact
1.5.1 How the Covid-19 is Affecting the Personalized Medicines Industry
1.5.1.1 Personalized Medicines Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Personalized Medicines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Personalized Medicines Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered
2 Global Personalized Medicines Market Competition by Manufacturers
2.1 Global Personalized Medicines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Personalized Medicines Revenue Share by Manufacturers (2015-2020)
2.3 Global Personalized Medicines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Personalized Medicines Manufacturing Sites, Area Served, Product Type
2.5 Personalized Medicines Market Competitive Situation and Trends
2.5.1 Personalized Medicines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Personalized Medicines Players (Opinion Leaders)
3 Personalized Medicines Retrospective Market Scenario by Region
3.1 Global Personalized Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Personalized Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Personalized Medicines Market Facts & Figures by Country
3.3.1 North America Personalized Medicines Sales by Country
3.3.2 North America Personalized Medicines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Personalized Medicines Market Facts & Figures by Country
3.4.1 Europe Personalized Medicines Sales by Country
3.4.2 Europe Personalized Medicines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Personalized Medicines Market Facts & Figures by Region
3.5.1 Asia Pacific Personalized Medicines Sales by Region
3.5.2 Asia Pacific Personalized Medicines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Personalized Medicines Market Facts & Figures by Country
3.6.1 Latin America Personalized Medicines Sales by Country
3.6.2 Latin America Personalized Medicines Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Personalized Medicines Market Facts & Figures by Country
3.7.1 Middle East and Africa Personalized Medicines Sales by Country
3.7.2 Middle East and Africa Personalized Medicines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Personalized Medicines Historic Market Analysis by Type
4.1 Global Personalized Medicines Sales Market Share by Type (2015-2020)
4.2 Global Personalized Medicines Revenue Market Share by Type (2015-2020)
4.3 Global Personalized Medicines Price Market Share by Type (2015-2020)
4.4 Global Personalized Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Personalized Medicines Historic Market Analysis by Application
5.1 Global Personalized Medicines Sales Market Share by Application (2015-2020)
5.2 Global Personalized Medicines Revenue Market Share by Application (2015-2020)
5.3 Global Personalized Medicines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Personalized Medicines Business
6.1 3G Biotech
6.1.1 Corporation Information
6.1.2 3G Biotech Description, Business Overview
6.1.3 3G Biotech Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3G Biotech Products Offered
6.1.5 3G Biotech Recent Development
6.2 Qiagen
6.2.1 Corporation Information
6.2.2 Qiagen Description, Business Overview
6.2.3 Qiagen Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Qiagen Products Offered
6.2.5 Qiagen Recent Development
6.3 Quest Diagnostics
6.3.1 Corporation Information
6.3.2 Quest Diagnostics Description, Business Overview
6.3.3 Quest Diagnostics Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Quest Diagnostics Products Offered
6.3.5 Quest Diagnostics Recent Development
6.4 Abbott
6.4.1 Corporation Information
6.4.2 Abbott Description, Business Overview
6.4.3 Abbott Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbott Products Offered
6.4.5 Abbott Recent Development
6.5 Agendia NV
6.5.1 Corporation Information
6.5.2 Agendia NV Description, Business Overview
6.5.3 Agendia NV Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Agendia NV Products Offered
6.5.5 Agendia NV Recent Development
6.6 Laboratory Corporation of America
6.6.1 Corporation Information
6.6.2 Laboratory Corporation of America Description, Business Overview
6.6.3 Laboratory Corporation of America Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Laboratory Corporation of America Products Offered
6.6.5 Laboratory Corporation of America Recent Development
6.7 CardioDx Inc.
6.7.1 Corporation Information
6.7.2 CardioDx Inc. Description, Business Overview
6.7.3 CardioDx Inc. Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.7.4 CardioDx Inc. Products Offered
6.7.5 CardioDx Inc. Recent Development
6.8 Asuragen Inc
6.8.1 Corporation Information
6.8.2 Asuragen Inc Description, Business Overview
6.8.3 Asuragen Inc Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Asuragen Inc Products Offered
6.8.5 Asuragen Inc Recent Development
6.9 Foundation Medicine
6.9.1 Corporation Information
6.9.2 Foundation Medicine Description, Business Overview
6.9.3 Foundation Medicine Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Foundation Medicine Products Offered
6.9.5 Foundation Medicine Recent Development
6.10 Becton Dickinson
6.10.1 Corporation Information
6.10.2 Becton Dickinson Description, Business Overview
6.10.3 Becton Dickinson Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Becton Dickinson Products Offered
6.10.5 Becton Dickinson Recent Development
6.11 Sanofi
6.11.1 Corporation Information
6.11.2 Sanofi Description, Business Overview
6.11.3 Sanofi Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sanofi Products Offered
6.11.5 Sanofi Recent Development
6.12 Illumina
6.12.1 Corporation Information
6.12.2 Illumina Description, Business Overview
6.12.3 Illumina Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Illumina Products Offered
6.12.5 Illumina Recent Development
6.13 23andMe
6.13.1 Corporation Information
6.13.2 23andMe Description, Business Overview
6.13.3 23andMe Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 23andMe Products Offered
6.13.5 23andMe Recent Development
6.14 Siemens Healthcare
6.14.1 Corporation Information
6.14.2 Siemens Healthcare Description, Business Overview
6.14.3 Siemens Healthcare Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Siemens Healthcare Products Offered
6.14.5 Siemens Healthcare Recent Development
6.15 GE Healthcare
6.15.1 Corporation Information
6.15.2 GE Healthcare Description, Business Overview
6.15.3 GE Healthcare Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 GE Healthcare Products Offered
6.15.5 GE Healthcare Recent Development
6.16 Bristol-Myers Squibb
6.16.1 Corporation Information
6.16.2 Bristol-Myers Squibb Description, Business Overview
6.16.3 Bristol-Myers Squibb Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Bristol-Myers Squibb Products Offered
6.16.5 Bristol-Myers Squibb Recent Development
6.17 Pfizer
6.17.1 Corporation Information
6.17.2 Pfizer Description, Business Overview
6.17.3 Pfizer Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Pfizer Products Offered
6.17.5 Pfizer Recent Development
7 Personalized Medicines Manufacturing Cost Analysis
7.1 Personalized Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Personalized Medicines
7.4 Personalized Medicines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Personalized Medicines Distributors List
8.3 Personalized Medicines Customers
9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)
10 Global Market Forecast
10.1 Global Personalized Medicines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Personalized Medicines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Personalized Medicines by Type (2021-2026)
10.2 Personalized Medicines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Personalized Medicines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Personalized Medicines by Application (2021-2026)
10.3 Personalized Medicines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Personalized Medicines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Personalized Medicines by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Personalized Medicines
1.2 Personalized Medicines Segment by Type
1.2.1 Global Personalized Medicines Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Personalized Medicines Segment by Application
1.3.1 Personalized Medicines Sales Comparison by Application: (2020-2026)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Global Personalized Medicines Market Size Estimates and Forecasts
1.4.1 Global Personalized Medicines Revenue 2015-2026
1.4.2 Global Personalized Medicines Sales 2015-2026
1.4.3 Personalized Medicines Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Personalized Medicines Industry Impact
1.5.1 How the Covid-19 is Affecting the Personalized Medicines Industry
1.5.1.1 Personalized Medicines Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Personalized Medicines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Personalized Medicines Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered
2 Global Personalized Medicines Market Competition by Manufacturers
2.1 Global Personalized Medicines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Personalized Medicines Revenue Share by Manufacturers (2015-2020)
2.3 Global Personalized Medicines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Personalized Medicines Manufacturing Sites, Area Served, Product Type
2.5 Personalized Medicines Market Competitive Situation and Trends
2.5.1 Personalized Medicines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Personalized Medicines Players (Opinion Leaders)
3 Personalized Medicines Retrospective Market Scenario by Region
3.1 Global Personalized Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Personalized Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Personalized Medicines Market Facts & Figures by Country
3.3.1 North America Personalized Medicines Sales by Country
3.3.2 North America Personalized Medicines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Personalized Medicines Market Facts & Figures by Country
3.4.1 Europe Personalized Medicines Sales by Country
3.4.2 Europe Personalized Medicines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Personalized Medicines Market Facts & Figures by Region
3.5.1 Asia Pacific Personalized Medicines Sales by Region
3.5.2 Asia Pacific Personalized Medicines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Personalized Medicines Market Facts & Figures by Country
3.6.1 Latin America Personalized Medicines Sales by Country
3.6.2 Latin America Personalized Medicines Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Personalized Medicines Market Facts & Figures by Country
3.7.1 Middle East and Africa Personalized Medicines Sales by Country
3.7.2 Middle East and Africa Personalized Medicines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Personalized Medicines Historic Market Analysis by Type
4.1 Global Personalized Medicines Sales Market Share by Type (2015-2020)
4.2 Global Personalized Medicines Revenue Market Share by Type (2015-2020)
4.3 Global Personalized Medicines Price Market Share by Type (2015-2020)
4.4 Global Personalized Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Personalized Medicines Historic Market Analysis by Application
5.1 Global Personalized Medicines Sales Market Share by Application (2015-2020)
5.2 Global Personalized Medicines Revenue Market Share by Application (2015-2020)
5.3 Global Personalized Medicines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Personalized Medicines Business
6.1 3G Biotech
6.1.1 Corporation Information
6.1.2 3G Biotech Description, Business Overview
6.1.3 3G Biotech Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3G Biotech Products Offered
6.1.5 3G Biotech Recent Development
6.2 Qiagen
6.2.1 Corporation Information
6.2.2 Qiagen Description, Business Overview
6.2.3 Qiagen Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Qiagen Products Offered
6.2.5 Qiagen Recent Development
6.3 Quest Diagnostics
6.3.1 Corporation Information
6.3.2 Quest Diagnostics Description, Business Overview
6.3.3 Quest Diagnostics Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Quest Diagnostics Products Offered
6.3.5 Quest Diagnostics Recent Development
6.4 Abbott
6.4.1 Corporation Information
6.4.2 Abbott Description, Business Overview
6.4.3 Abbott Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbott Products Offered
6.4.5 Abbott Recent Development
6.5 Agendia NV
6.5.1 Corporation Information
6.5.2 Agendia NV Description, Business Overview
6.5.3 Agendia NV Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Agendia NV Products Offered
6.5.5 Agendia NV Recent Development
6.6 Laboratory Corporation of America
6.6.1 Corporation Information
6.6.2 Laboratory Corporation of America Description, Business Overview
6.6.3 Laboratory Corporation of America Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Laboratory Corporation of America Products Offered
6.6.5 Laboratory Corporation of America Recent Development
6.7 CardioDx Inc.
6.7.1 Corporation Information
6.7.2 CardioDx Inc. Description, Business Overview
6.7.3 CardioDx Inc. Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.7.4 CardioDx Inc. Products Offered
6.7.5 CardioDx Inc. Recent Development
6.8 Asuragen Inc
6.8.1 Corporation Information
6.8.2 Asuragen Inc Description, Business Overview
6.8.3 Asuragen Inc Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Asuragen Inc Products Offered
6.8.5 Asuragen Inc Recent Development
6.9 Foundation Medicine
6.9.1 Corporation Information
6.9.2 Foundation Medicine Description, Business Overview
6.9.3 Foundation Medicine Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Foundation Medicine Products Offered
6.9.5 Foundation Medicine Recent Development
6.10 Becton Dickinson
6.10.1 Corporation Information
6.10.2 Becton Dickinson Description, Business Overview
6.10.3 Becton Dickinson Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Becton Dickinson Products Offered
6.10.5 Becton Dickinson Recent Development
6.11 Sanofi
6.11.1 Corporation Information
6.11.2 Sanofi Description, Business Overview
6.11.3 Sanofi Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sanofi Products Offered
6.11.5 Sanofi Recent Development
6.12 Illumina
6.12.1 Corporation Information
6.12.2 Illumina Description, Business Overview
6.12.3 Illumina Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Illumina Products Offered
6.12.5 Illumina Recent Development
6.13 23andMe
6.13.1 Corporation Information
6.13.2 23andMe Description, Business Overview
6.13.3 23andMe Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 23andMe Products Offered
6.13.5 23andMe Recent Development
6.14 Siemens Healthcare
6.14.1 Corporation Information
6.14.2 Siemens Healthcare Description, Business Overview
6.14.3 Siemens Healthcare Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Siemens Healthcare Products Offered
6.14.5 Siemens Healthcare Recent Development
6.15 GE Healthcare
6.15.1 Corporation Information
6.15.2 GE Healthcare Description, Business Overview
6.15.3 GE Healthcare Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 GE Healthcare Products Offered
6.15.5 GE Healthcare Recent Development
6.16 Bristol-Myers Squibb
6.16.1 Corporation Information
6.16.2 Bristol-Myers Squibb Description, Business Overview
6.16.3 Bristol-Myers Squibb Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Bristol-Myers Squibb Products Offered
6.16.5 Bristol-Myers Squibb Recent Development
6.17 Pfizer
6.17.1 Corporation Information
6.17.2 Pfizer Description, Business Overview
6.17.3 Pfizer Personalized Medicines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Pfizer Products Offered
6.17.5 Pfizer Recent Development
7 Personalized Medicines Manufacturing Cost Analysis
7.1 Personalized Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Personalized Medicines
7.4 Personalized Medicines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Personalized Medicines Distributors List
8.3 Personalized Medicines Customers
9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)
10 Global Market Forecast
10.1 Global Personalized Medicines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Personalized Medicines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Personalized Medicines by Type (2021-2026)
10.2 Personalized Medicines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Personalized Medicines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Personalized Medicines by Application (2021-2026)
10.3 Personalized Medicines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Personalized Medicines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Personalized Medicines by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
